- ABOUT US
- MEETINGS AND EDUCATION
|Registration: ISCT Webinar, Presented by the ISCT Business Models and Investment Subcommittee|
Challenges and Potential Solutions for Taking Your Cell and Gene Therapy Clinical Program to Japan
Chair: David Smith, MEng, PhD, Biomedical Engineer, Hitachi Chemical Advanced Therapeutics Solutions, LLC, United States
As a result of this recent partnership, the ISCT Business Model & Investment Subcommittee has planned a two-part series on CGT development and business opportunities in Japan.
This first session will focus on the PPD and regulatory considerations for taking your CGT clinical program to Japan. Participants will learn about the attractive regulatory changes at PMDA which have resulted in increased offshore filing activity in Japan, the challenges to consider, and examples of solutions for successfully bringing CGT programs to Japan.
The second session in 2018 will be more focused on partnering and the value of adding Japan to your CGT program. These are must-attend webinars if you are considering Japan as part of your business model!